Inhibition of nitric oxide synthesis is detrimental during endotoxemia

Arch Surg. 1994 Feb;129(2):142-7; discussion 147-8. doi: 10.1001/archsurg.1994.01420260038004.

Abstract

Background: Increased production of nitric oxide has been implicated as a mediator during septic shock and sepsis syndrome. Inhibition of nitric oxide production could be beneficial during endotoxemia to improve the individual's hemodynamic status and possibly outcome.

Objective: To evaluate the effects of nitric oxide inhibition on macrophage function and survival in a murine sepsis model.

Design: Sixty-eight female Swiss-Webster (ND4) mice were injected with a sublethal dose of Escherichia coli lipopolysaccharide (25 mg/kg).

Intervention: The treated group (n = 34) received 10 mg/kg of NG-nitro-L-arginine methyl ester at the time of lipopolysaccharide injection.

Main outcome measures: Blood samples and peritoneal macrophages were obtained at baseline and at 2, 4, and 8 hours after injection. Nitrite levels were measured in 36 mice from plasma and supernatant samples of cultured peritoneal macrophages stimulated with interferon gamma (100 micrograms/mL) for 48 hours. Thirty-two animals were observed for survival.

Results: Administration of N-nitro-L-arginine methyl ester after lipopolysaccharide injection caused significant reductions in macrophage mean nitrite production from 13 and 15 mumol/L to 7 and 11 mumol/L (P < .05) and reduced mean plasma nitrite concentrations from 100 and 118 mumol/L to 46 and 108 mumol/L (P < .05) at 2 and 4 hours, respectively. The rate of survival was significantly decreased to 0% in the group receiving N-nitro-L-arginine methyl ester after septic challenge compared with 87.5% in controls (P < .005).

Conclusions: Inhibition of nitric oxide production is detrimental in this murine model of endotoxemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / analogs & derivatives*
  • Arginine / pharmacology
  • Endotoxins / adverse effects*
  • Endotoxins / blood
  • Escherichia coli*
  • Female
  • Lipopolysaccharides / adverse effects*
  • Lipopolysaccharides / blood
  • Lung / enzymology
  • Lung / pathology
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Mice
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide / antagonists & inhibitors*
  • Nitric Oxide / biosynthesis
  • Nitrites / blood
  • Peroxidase / metabolism
  • Superoxides / metabolism
  • Survival Rate

Substances

  • Endotoxins
  • Lipopolysaccharides
  • Nitrites
  • Superoxides
  • Nitric Oxide
  • Arginine
  • Peroxidase
  • NG-Nitroarginine Methyl Ester